NanoGuardian Launches New Website to Fight Illegal Diversion and Counterfeiting of Pharmaceuticals

Published on January 7, 2009 at 6:07 PM

NanoGuardian, a division of NanoInk®, launched a new Web site today, which is dedicated to providing useful information and resources to fight illegal diversion and counterfeiting of pharmaceuticals. The new Web site,, also provides detailed information on NanoGuardian's state-of-the-art, on-dose brand protection solution, NanoEncryption™ technology and NanoGuardian's proactive market-monitoring program, Closed-Loop Protection™.

"The new NanoGuardian Web site is a resource for those in government, law enforcement and any industry that is affected by illegal counterfeiting and diversion of its products," said Dean Hart, executive vice president of NanoGuardian. "We also encourage visitors to learn about our novel NanoEncryption technology, which is the only on-dose, multi-layered, brand protection solution that enables pharmaceutical manufacturers to trace and authenticate every single dose from plant to patient. Complementing our NanoEncryption technology is our Closed-Loop Protection market-monitoring program, which serves as an early warning system to manufacturers in the detection of counterfeit and diverted product."

The Web site also provides continuous updates on new reports of counterfeited and illegally diverted products in the marketplace as well as past press releases and news articles.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback